Trial Profile
The Real Life Topical Field Treat-ment of Actinic Keratosis Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary) ; Fluorouracil (Primary) ; Imiquimod (Primary) ; Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 11 May 2016 Status changed from active, no longer recruiting to completed.
- 29 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
- 02 Dec 2014 New trial record